Novartis shared today the difficult news that they are stopping the VIBRANT-HD study of Branaplam, after some participants devoloping side effects.

Even if this news can be disappointing, the HD Community will keep positive and hope the remaining trials and tests can bring some good news.

分类: 新闻

0 条评论

发表回复

头像占位符

您的电子邮箱地址不会被公开。 必填项已用*标注

zh_CNChinese